Novavax said on Tuesday it was entering into a licensing agreement with Pfizer to develop vaccine products for ...
Biopharmaceutical company Agomab Therapeutics filed for an initial public offering in the United States on Friday.
Pfizer Inc. and Boltz, PBC, an applied AI research lab, today announced a strategic collaboration to empower scientists ...
Pfizer stock has been a weak performer, declining by about 7% through 2025. Things could remain mixed over 2026 as well, with the company guiding for revenues of $59.5-$62.5 billion and adjusted EPS ...
Britain's GSK is set to acquire RAPT Therapeutics for $2.2 billion. This move brings the experimental food allergy drug ...
Business leaders are urged to defend free markets against government control. Many top executives are hesitant to openly ...
All 16 drug companies that inked deals with the Trump administration over the past few months still raised some of their ...
On the first day of the JPM Healthcase Conference, AbbVie announced that it would acquire the global rights outside China to ...
Anthony Fauci privately acknowledged “impressive data” showed stronger immunity from a COVID-19 infection than vaccination ...
Every January, pharmaceutical companies increase the prices of hundreds of drugs. This year there's a disconnect between the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback